<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Discussion Board - Unit II by </title>
      <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951</link>
      <description>Autonomic Nervous System and Respiratory System</description>
      <language>en-us</language>
      <pubDate>2021-06-25 20:00:14 UTC</pubDate>
      <lastBuildDate>2026-03-15 18:00:00 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f338.png</url>
      </image>
      <item>
         <title>1.  The two divisions of the ANS and alternate names associated with each:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874064</link>
         <description><![CDATA[<div>- Parasympathetic Nervous System 'PNS' <em>(alt name: Craniosacral Division; craniosacral &amp; cholinergic)</em><br>-Sympathetic Nervous System 'SNS' <em>(alt name: Thoracolumbar Division; thoracolumbar &amp; adrenergic)</em></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1252503093/55bade3070d118a9f3687c71638bbf4f/ANS.gif" />
         <pubDate>2021-06-25 20:21:18 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874064</guid>
      </item>
      <item>
         <title>2.  The neurotransmitters for each division:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874471</link>
         <description><![CDATA[<div>- Parasympathetic Nervous System: <em>Acetylcholine</em><br>- Sympathetic Nervous System: <em>Epinephrine &amp; Norepinephrine</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:21:54 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874471</guid>
      </item>
      <item>
         <title>3.  The locations where each NT is released in each division of the ANS:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874725</link>
         <description><![CDATA[<div>- PNS: <em>Acetylcholine is release in the postganglionic nerve endings</em><br><br>- SNS: <br>*<em>Norepinephrine is released in adrenal medulla &amp; neurons</em><br><br>*<em>Epinephrine is released in postganglionic nerve endings</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:22:18 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625874725</guid>
      </item>
      <item>
         <title>4.  The receptors of each division with main locations of each receptor:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625875148</link>
         <description><![CDATA[<div>- PNS: <em>Muscarinic &amp; Nicotini</em>c<br>*Muscarinic - located on the cells membranes of visceral organs &amp; glands.<br>*Nicotinic - two types of nicotinic receptors (Nicotinic-1 [Nm = Nicotinic muscle] &amp; Nicotinic-2 [Nn = Nicotinic muscle]<br><br>- SNS: <em>Divided into two types of receptors (alpha &amp; beta)</em><br>*alpha-1: <em>glands, eyes, smooth muscle..</em><br><br>*alpha-2: <em>adrenergic nerve endings</em><br><br>*beta-1: <em>located on the heart</em><br><br>*beta-2: <em>smooth muscles, lungs, uterus..</em><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:22:55 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625875148</guid>
      </item>
      <item>
         <title>5.  The end organ responses that occur when each transmitter is stimulated. List the specific organ and state what response is generated in that organ when stimulated by each ANS division:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625875435</link>
         <description><![CDATA[<div>- PNS: <br>*Arteries: <em>not supplied by parasympathetic nerves</em><br>*Heart: <em>decreases heart rate &amp; atrioventricular conduction</em><br>*GI Tract: <em>Increases</em><br>*Post ganglionic transmitter: <em>releases ACH</em><br>*Pupil: <em>experiences miosis</em><br>*Respiratory passages: <em>bronchoconstriction</em><br>*Urinary Bladder: <em>contracts</em><br>*Urinary Sphincter: <em>experiences relaxation<br><br>- SNS:<br>*</em>Adrenal medulla<em>: releases EPI<br>*</em>Arteries<em>: vasoconstriction (exceptions are coronary arteries &amp; skeletal muscle arteries)<br>*</em>Heart<em>: increases heart rate &amp; atrioventricular conduction<br>*</em>GI Tract<em>: Decreases<br>*</em>Post ganglionic transmitter<em>: releases NE<br>*</em>Pupil<em>: Mydriasis<br>*</em>Respiratory passages<em>: Bronchonstriction<br>*</em>Urinary bladder<em>: experiences relaxation<br>*</em>Urinary Sphincter<em>: contracts</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:23:18 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625875435</guid>
      </item>
      <item>
         <title>6.  The drug classifications for each division of the ANS. Under each classification, identify which receptors are interacted with, then include the action that occurs:</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625877262</link>
         <description><![CDATA[<div>- PNS: <br>*Parasympathomimetic: <em>drugs that mimic the parasympathetic system ---&gt; cholinergic &amp; antagonists</em><br>*Parasympatholytics: <em>drugs that work against the parasympathetic system ---&gt; anticholinergic &amp; antagonist<br><br>-</em>Receptors<em>:<br>*</em>Muscarinic<em>: decreases heart rate, bronchoconstriction, digestion increases along w/ GI, urinary secretions &amp; pupillary constriction.<br>*</em>Nicotinic (Nm)<em>: depolarization in ganglia which results in post ganglionic impulse<br>*</em>Nicotinic (Nn)<em>: neuromuscular junction of muscle &amp; if stimulated the muscle contracts.<br><br>- </em>SNS<em>:<br>*</em>Sympathomimetics<em>: drugs that mimic the sympathetic system (adrenergic &amp; agonists)<br>*</em>Sympatholytic<em>s: drugs that work against the sympathetic system (adrenergic blocking, blockers &amp; inhibitor antagonists)<br><br>-</em>Receptors<em>:<br>*</em>Alpha-1<em>: smooth muscle contraction<br>*</em>Alpha-2<em>: decreases contraction of smooth muscle<br>*</em>Beta-1<em>: increase force of contraction<br>*</em>Beta-2<em>: smooth muscle relaxation</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:23:52 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625877262</guid>
      </item>
      <item>
         <title>7.  The specific drug examples found on your drug list under each drug classification including generic (lowercase) and brand (capitalized in parentheses with the trademark symbol at the end- ®):</title>
         <author>cinnamonwalker</author>
         <link>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625879290</link>
         <description><![CDATA[<div><strong>Alpha-1 Adrenergic Agonists:<br></strong><em>increase circulation of vital organs, increase BP, and promote digestion<br>*</em>ephedrine<strong><br>&nbsp; &nbsp; &nbsp; &nbsp;</strong><em>increases BP<br>*</em>phenylephrine (Neo-Synephrine®)<strong><br>&nbsp; &nbsp; &nbsp; &nbsp;</strong><em>increases BP, nasal&nbsp; &nbsp; &nbsp; &nbsp; congesting</em></div><div><br></div><div><strong>Adrenergic Agonists: </strong><em>severe allergic reactions/anaphylaxis, shock, and cardiac arrhythmias<br>*</em><strong>epinephrine (Adrenalin®)<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong><em>increases heart rate and BP, cardiac stimulant, bronchodilator</em></div><div><br></div><div><strong>Alpha-1 Adrenergic Blocker: </strong><em>hypertension, benign prostatic hyperplasia<br>*</em><strong>prazosin (Minipress®)<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong><em>HTN<br>*</em><strong>terazosin (Hytrin®)<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </strong><em>HTN &amp; BPH<br>*</em><strong>doxazosin&nbsp; (Cardura®)<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong><em>HTN &amp; BPH<br>&nbsp;Orthostatic hypertension - causation with position changes, reflex tachycardia, GI upset, and increased urination</em></div><div><br></div><div><strong>Beta-1 Adrenergic Agonist: </strong><em>treatment of shock, increases blood pressure, and increases heart function<br>*</em><strong>dobutamine<br>&nbsp; &nbsp; &nbsp; </strong><em>Overstimulation of the heart, CNS irritation</em></div><div><br></div><div><strong>Beta-2 Adrenergic Agonist: </strong><em>Asthma, respiratory illness/disease, preterm labor<br>Bronchodilators <br>*</em><strong>formoterol (Foradil®)<br>*albuterol (Proventil® Ventolin®)<br>*terbutaline (Brethine®</strong>)<br>&nbsp; &nbsp; &nbsp; &nbsp;<em>Tachycardia, jittery, tremors, headache</em></div><div><br></div><div><strong>Beta Blocker (Non-Selective):<br></strong><em>Hypertension (HTN) arrhythmias, angina, tachycardia, migraines, glaucoma (lowers IOP), heart failure (decreases sympathetic activity)<br>*</em><strong>nadolol (Corgard®)<br>*propranolol (Inderol®)<br>*timolol (Blocadren®) <br>&nbsp; &nbsp; &nbsp; &nbsp;</strong><em>drowsiness, GI upset, CNS depression, bradycardia, need to monitor serum lipid levels, mental depression, monitor glucose in diabetic</em></div><div><br></div><div><strong>Beta Blocker (Selective):<br></strong><em>Hypertension (HTN), angina, arrhythmias, tachycardia, migraines, glaucoma (lowers IOP), heart failure (decreases sympathetic activity)<br>*</em><strong>atenolol (Tenormin®)<br>*metoprolol (Lopressor®)<br></strong><em>drowsiness, GI upset, CNS depression, bradycardia, need to monitor serum lipid levels, mental depression, monitor glucose levels</em>&nbsp;</div><div><br></div><div><strong>Direct Acting Cholinergic Agonist<br>*acetylcholine (ACH)<br></strong><em>Used for miosis, cataract, and other eye surgeries<br>*MOA: pupil constriction<br>*</em><strong>pilocarpine (Pilocar®)<br>*</strong><em>Used for glaucoma<br>*MOA: pupil constriction; decreases the amount of fluid in eyes; decreases intraocular pressure<br><br>*</em><strong>bethanechol (Urecholine®)<br></strong><em>Used for urinary retention and ileus/intestinal stasis<br><br>MOA: stimulates muscarinic receptors of bladder and GI tract to prevent constipation and urinary retention post-op and in the elderly&nbsp;</em></div><div><br></div><div><strong>Indirect Acting Cholinergic Agents: </strong><em>Urinary retention and intestinal stasis/ileus, reversal of anticholinergicrocuronium bromide (Zemuron®) with respiratory paralysis from anesthesia by increasing ACH at the nicotinic 2 (NM) receptors on skeleton muscle, treatment for myasthenia gravis<br>*</em><strong>neostigmine (Prostigmin®)<br></strong><em>Lacrimation, urinary incontinence, emesis (sLUdgE)</em></div><div><br></div><div><strong>Anticholinergic <br>*atropine<br></strong><em>Used as an antidote for cholinergic poisoning<br><br>Increases heart rate (HR), decreases vague nerve activity (parasympathetic), pre-op medicine slows digestion and urination, mydriasis<br>*</em><strong>dicyclomine (Bentyl®)<br></strong><em>Used for GI disorders (ulcers, colitis, IBS)</em></div><div><em>Decreases GI secretions and motility<br><br></em><strong>ipratropium bromide (Atrovent®) <br>*</strong><em>bronchodilation</em></div><div><br></div><div><strong>Skeletal Muscle Relaxants (A)</strong><br>&nbsp; &nbsp; &nbsp;<em>* Peripherally Acting&nbsp; &nbsp; &nbsp; *</em><strong>succinylcholine</strong></div><div>&nbsp; &nbsp; &nbsp; &nbsp; Depolarizing Agent<br><em>Uses: intubation, adjunct therapy for general anasthesia<br><br>(Fasiculatations) Pain, jaw riggidity, hypotension, arrhythmias, potential for toxicity if cholinesterase is abnormal, malignment hypothermia - obtain family history, should only be used in emergent situations in pediatric patients</em></div><div><br></div><ul><li><strong>recuronium bromide (Zemuron®)</strong></li></ul><div>&nbsp; &nbsp; &nbsp; &nbsp; Non-depolarizing Agent</div><ul><li><em>Used for intubation, adjunct therapy for general anasthesia, and mechanical ventilation</em></li><li><em>(Fasiculations) pain, jaw riggidity, hypotension, arrhythmias, respiratory depression</em></li></ul><div><br></div><ul><li><strong>dantrolene (Dantrium®)</strong></li></ul><div>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Direct Acting</div><ul><li><em>Used for spastic conditions, ie. cerebral palsy, multiple sclerosis, sprinal cord injuries, malignment hyperthermia</em></li><li><em>Hepatotoxicity - box warning, vomiting, dizziness, fatigue, weakness</em></li></ul><div><br></div><div><strong>Skeletal Muscle Relaxants (B): </strong><em>spasms, injury, tension, overexertion</em><br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Centrally Acting<br>*<strong>cyclobenzaprine (Flexeril®)<br>*carisoprodol (Soma®)<br>*methocarbamol (Robaxin®)<br>*orphenadrine citrate (Norflex®)<br>*chlorzoxazone (Parafon Forte DSC®)<br>*metaxalone (Skelaxin®)</strong></div><div><br><em>Blurred vision, fatigue, decreased mental alertness, lethargy, dizziness, decreased muscle tone, hypotension, avoid alcohol, patients may need to avoid operating a vehicle if effects are intense</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2021-06-25 20:24:43 UTC</pubDate>
         <guid>https://padlet.com/cinnamonwalker/b35y6mqsjgyth951/wish/1625879290</guid>
      </item>
   </channel>
</rss>
